X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (53) 53
female (47) 47
index medicus (39) 39
oncology (31) 31
breast cancer (23) 23
middle aged (20) 20
adult (19) 19
cancer (19) 19
610 medicine & health (15) 15
breast neoplasms - pathology (14) 14
chemotherapy (13) 13
clinic for gynecology (12) 12
medicine & public health (11) 11
immunohistochemistry (10) 10
research (10) 10
aged (9) 9
breast neoplasms - drug therapy (9) 9
cost-effectiveness (9) 9
experiment (9) 9
analysis (8) 8
genetic aspects (8) 8
high energy physics - experiment (8) 8
particle physics (8) 8
physics (8) 8
prognosis (8) 8
retrospective studies (8) 8
aged, 80 and over (7) 7
antineoplastic agents - therapeutic use (7) 7
care and treatment (7) 7
cell line, tumor (7) 7
cost-benefit analysis (7) 7
endometrial cancer (7) 7
fysik (7) 7
mutation (7) 7
natural sciences (7) 7
naturvetenskap (7) 7
physical sciences (7) 7
physics - high energy physics - experiment (7) 7
switzerland (7) 7
breast neoplasms - mortality (6) 6
cancer research (6) 6
diagnosis (6) 6
disease-free survival (6) 6
endometrial neoplasms - genetics (6) 6
homologous recombination (6) 6
male (6) 6
metastasis (6) 6
ovarian cancer (6) 6
pathology (6) 6
surgery (6) 6
therapy (6) 6
treatment outcome (6) 6
[ phys.hexp ] physics [physics]/high energy physics - experiment [hep-ex] (5) 5
apoptosis (5) 5
breast (5) 5
breast neoplasms - genetics (5) 5
case report (5) 5
chemotherapy, adjuvant (5) 5
dna mutational analysis (5) 5
endometrial neoplasms - pathology (5) 5
endometriosis (5) 5
estrogen (5) 5
health aspects (5) 5
kaplan-meier estimate (5) 5
lesions (5) 5
microsatellite instability (5) 5
obstetrics & gynecology (5) 5
poly polymerase (5) 5
subatomic physics (5) 5
subatomär fysik (5) 5
time factors (5) 5
tissue array analysis (5) 5
usage (5) 5
women (5) 5
antineoplastic agents - pharmacology (4) 4
biomarkers, tumor - analysis (4) 4
biomarkers, tumor - genetics (4) 4
biomarkers, tumor - metabolism (4) 4
biopsy (4) 4
breast neoplasms - chemistry (4) 4
breast neoplasms - metabolism (4) 4
breast-cancer (4) 4
carcinoma (4) 4
cell biology (4) 4
classification (4) 4
clinical trials as topic (4) 4
development and progression (4) 4
dna mismatch repair (4) 4
dna repair (4) 4
endometrial neoplasms - drug therapy (4) 4
enzyme inhibitors - pharmacology (4) 4
expression (4) 4
gene expression (4) 4
gene mutations (4) 4
gene-expression (4) 4
genes (4) 4
genetics (4) 4
histone deacetylase inhibitors (4) 4
hydroxamic acids - pharmacology (4) 4
institute of pathology and molecular pathology (4) 4
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


SWISS MEDICAL WEEKLY, ISSN 1424-7860, 08/2019, Volume 149, p. w20092
BACKGROUND: Since the advent of high-throughput sequencing technologies, organised germline screening, independent of the personal and family cancer history,... 
MUTATION ANALYSIS | EXOME | Italian | population-based screening | VARIANTS | AMERICAN-COLLEGE | MEDICAL GENETICS | Swiss | BRCA MUTATIONS | INCIDENTAL FINDINGS | MEDICINE, GENERAL & INTERNAL | universal screening | HIGH-RISK | hereditary breast and ovarian cancer (HBOC) | genetic incidentaloma | secondary findings | DNA-REPAIR | CLINICAL-SIGNIFICANCE
Journal Article
Journal Article
Oncotarget, ISSN 1949-2553, 2014, Volume 5, Issue 14, pp. 5295 - 5303
ARID1A mutations are observed in various tumors, including ovarian clear cell (OCCC) and endometrioid carcinomas, endometrial, and breast carcinomas. They... 
BAF250a | Endometriosis associated ovarian carcinomas | Endometrial cancer | Perifosine | AKT-inhibitor | Buparlisib (BKM120) | Breast cancer | ARID1A | PI3K/AKT pathway | PIK3CA | SWI/SNF | MK-2206 | PI3K-inhibitor | AKT phosphorylation | Ovarian clear cell carcinomas | Apoptosis | RNA, Small Interfering - genetics | Phosphorylation | Apoptosis - drug effects | Heterocyclic Compounds, 3-Ring - pharmacology | Humans | Transcription Factors - deficiency | Phosphatidylinositol 3-Kinases - metabolism | Phosphorylcholine - analogs & derivatives | Phosphatidylinositol 3-Kinases - antagonists & inhibitors | Proto-Oncogene Proteins c-akt - genetics | Breast Neoplasms - metabolism | Gene Knockdown Techniques | Breast Neoplasms - therapy | Breast Neoplasms - enzymology | Transfection | MCF-7 Cells | Nuclear Proteins - biosynthesis | Nuclear Proteins - deficiency | Phosphorylcholine - pharmacology | Female | Nuclear Proteins - genetics | Proto-Oncogene Proteins c-akt - metabolism | Ribosomal Protein S6 Kinases, 70-kDa - metabolism | Signal Transduction | Morpholines - pharmacology | Nuclear Proteins - metabolism | Transcription Factors - biosynthesis | Transcription Factors - genetics | Transcription Factors - metabolism | Breast Neoplasms - pathology | Aminopyridines - pharmacology | Protein Kinase Inhibitors - pharmacology | Apoptosis - physiology | RNA, Small Interfering - administration & dosage | Proto-Oncogene Proteins c-akt - antagonists & inhibitors
Journal Article
Cell Cycle, ISSN 1538-4101, 04/2011, Volume 10, Issue 8, pp. 1192 - 1199
Journal Article
PLoS ONE, ISSN 1932-6203, 06/2014, Volume 9, Issue 6, p. e100041
Aim of the study: To evaluate the frequency of MRE11/RAD50/NBS1 (MRN)-complex loss of protein expression in endometrial cancers (EC) and to determine whether... 
COMPLEX | STRAND BREAK REPAIR | REPLICATION FORKS | MICROSATELLITE INSTABILITY | COLORECTAL-CANCER | MULTIDISCIPLINARY SCIENCES | MUTATIONS | DNA-REPAIR | EXPRESSION | CARCINOMA | CELL-LINE | Prognosis | Humans | Endometrial Neoplasms - metabolism | Carcinoma, Endometrioid - diagnosis | DNA Mismatch Repair - genetics | Carcinoma, Endometrioid - metabolism | Gene Knockdown Techniques | DNA-Binding Proteins - metabolism | MRE11 Homologue Protein | Endometrial Neoplasms - genetics | Female | Tumor Cells, Cultured | Recombinational DNA Repair - drug effects | Rad51 Recombinase - metabolism | Carcinoma, Endometrioid - genetics | Rad51 Recombinase - genetics | Recombinational DNA Repair - genetics | DNA Mismatch Repair - drug effects | DNA-Binding Proteins - genetics | Endometrial Neoplasms - diagnosis | Poly(ADP-ribose) Polymerase Inhibitors - pharmacology | Drug Resistance, Neoplasm - genetics | Endometrial Neoplasms - pathology | Biomarkers, Pharmacological - metabolism | Carcinoma, Endometrioid - pathology | Immunohistochemistry | Ionizing radiation | Endometrial cancer | Sugars | Cancer | Monosaccharides | Biotechnology | Carcinoma | Homologous recombination | Genes | Colorectal cancer | Poly(ADP-ribose) | Homology | ADP | DNA repair | Cancer therapies | Ribose | MRE11 protein | Mismatch repair | Repair | Endometrium | Deoxyribonucleic acid--DNA | Sensitivity analysis | Gynecology | Poly(ADP-ribose) polymerase | siRNA | Breast cancer | Radiation therapy | Tumor cell lines | Polymerase | Pathology | Chemotherapy | Sensitivity | Inhibitors | Medical prognosis | Cell lines | Irradiation | Biomarkers | Mutation | Tumors | Deoxyribonucleic acid | DNA
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2016, Volume 34, Issue 15_suppl, pp. 567 - 567
Journal Article
Nature Reviews Clinical Oncology, ISSN 1759-4774, 05/2011, Volume 8, Issue 5, pp. 302 - 306
Journal Article
The Journal of Nuclear Medicine, ISSN 0161-5505, 12/2018, Volume 59, Issue 12, p. 1817
The goal of this study was to determine the level of clinically acceptable 18F-FDG dose reduction in time-of-flight PET/MRI in patients with breast cancer.... 
Reconstruction | Radiation effects | Medical imaging | Noise | Radiation | Feasibility studies | Positron emission | Fluorine isotopes | Breast cancer | Mammography | Sharpness | Rank tests | Image quality | Artifacts | Reduction | Magnetic resonance imaging | Simulation | Mathematical analysis | Tomography | Breast | Qualitative analysis | Lesions | Positron emission tomography | Cancer
Journal Article
Journal of Nuclear Medicine, ISSN 0161-5505, 12/2018, Volume 59, Issue 12, pp. 1817 - 1822
Journal Article